F12.180 for mild cannabis use disorder with cannabis-induced anxiety disorder or F12.280
for a moderate or severe cannabis use diso rder with cannabis-induced anxiety disorder.
Specify current severity:
305.20 (F12.10) Mild:  Presence of 2–3 symptoms.
304.30 (F12.20) Moderate: Presence of 4–5 symptoms.
304.30 (F12.20) Severe:  Presence of 6 or more symptoms.
Specifiers
“In a controlled environment” app lies as a further specifier of remission if the individual is
both in remission and in a controlled environm ent (i.e., in early remission in a controlled
environment or in sustained remission in a controlled environmen t). Examples of these
environments are closely supe rvised and substanc e-free jails, therapeutic communities,
and locked hospital units. 
Changing severity across time in an individual may also be reflected by changes in the
frequency (e.g., days of use per month or ti mes used per day) and/or dose (e.g., amount
used per episode) of cannabis, as assessed by in dividual self-report, report of knowledge-
able others, clinician’s observ ations, and biological testing.
Diagnostic Features
Cannabis use disorder and the other cannabis-re lated disorders include problems that are
associated with substances derived from the cannabis plant and chemically similar syn-
thetic compounds. Over time, this plant material has accumulated many names (e.g.,
weed, pot, herb, grass, reefer, mary jane, da gga, dope, bhang, skunk, boom, gangster, kif,
and ganja). A concentrated extraction of the cannabis plant that is also commonly used is
hashish. Cannabis  is the generic and perhaps the most appropriate scientific term for the